Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: United States Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20033
20045
20064
20073
20083
20092
20101
20113
20122
20134
20145
20152
20161
20172
20182
20191
20202
20211
20232
20243
20254
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting14
Terminated13
Active, not recruiting5
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
Revolution Medicines, Inc.5
Astex Pharmaceuticals, Inc.3
Incyte Corporation3
M.D. Anderson Cancer Center3
SWOG Cancer Research Network3
Sanofi3
Alliance for Clinical Trials in Oncology2
Celgene2
Eastern Cooperative Oncology Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms76
Neoplasm Metastasis7
Neoplasms6
Adenocarcinoma3
Bile Duct Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Endocrine Gland Neoplasms3
Esophageal Neoplasms3
Liver Neoplasms3
Pancreatic Diseases3

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.